Get to know 2025 SITC At-Large Director candidate Aurélien Marabelle, MD, PhD (Gustave Roussy). Read Dr. Marabelle’s bio and position statement: https://t.co/qvoR2g3977
Happy that our #network was lauded last weekend 🥇—a testament to how, despite our often #perfectionist doctor mindset, we embrace #collaboration to find the best solutions for our patients #together.
@martheverhaert presenting our 2y experience of the #multidisciplinary#bitox meetings at #sitc2023 💪🏻
📈 a steady rise in cases show the accessibility and popularity
🫵 we keep looking for motivated #oncologists and #organ specialists to join
💌 us at [email protected] for more ℹ️
"Scientists searching for insights are increasingly convinced that changes to nutrition and ways of living that began in the middle of the last century hold at least part of the key to the puzzle." https://t.co/mKOrxV86C4
A new week, a fresh podcast on #livercancer( HCC ) @martheverhaert and @PJCuyle discuss the safety profile of new combinations and immunotherapy more generally. What should you pay attention to as a physician when initiating a new therapy? Listen now https://t.co/TC28wVaon9
📌 Launching in June: the #HCC podcast expert series
🎙 Using #podcasts to keep physicians informed on the newest insights in HCC treatment, with #ICI as new kids on the block 🏥
⏩ A great initiative to improve information dissemination and thus #safety of treatment!
Yesterday the recording for a brand new concept in the world of #livercancer took place. I can't wait to share the results with you. Stay tuned for the launch of the "HCC Podcast Expert Series, a medical pop-up concept" in June. 🙏to all speakers for sharing expert #GI insights
New #JITC position article and guidelines: Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology https://t.co/ZEXLoyAfRc @DrJNaidoo@JulieBrahmer@EladSharonMD @cappelliMD
In a prospective cohort of patients with advanced melanoma from the UK and the Netherlands, a Mediterranean dietary pattern was positively associated with response to immune checkpoint blockade. https://t.co/ccHGLFcCvS
What’s the prognostic meaning of irAEs in MSI CRC? 🤔
Not all irAEs are the same!
📈 ⬆️ outcomes if musculoskeletal and endocrine 🟢
BUT
📉 ⬇️prognosis if liver, GI, neuro and lung AEs 🔴
Check out our work, led by @FilippoPietran4#CRCsm#immunotherapy https://t.co/KEQ0d1MM3O
❔ Want to learn more about immunotherapy in the frail, elderly 🧓 or immunocompromised 🌡️ population?
👉 Register for the webinar on November 29th.
https://t.co/QuBukOOCPL